Last updated: August 18, 2025
Introduction
Patent KR20150129067, filed by a South Korean innovator, pertains to a novel pharmaceutical compound or formulation, reflecting strategic advancements in this area. Analyzing its scope, claims, and the associated patent landscape offers critical insights into its innovation strength, market exclusivity, and competitive positioning within the South Korean and global pharmaceutical sectors.
Scope of Patent KR20150129067
The scope defines the patent’s legal boundaries, encompassing technical features, claims, and potential applications. Patent KR20150129067 primarily encompasses:
- Pharmaceutical compositions, including specific active compounds and their combinations.
- Method of treatment, indicating the targeted disease states or conditions permissible within the patent rights.
- Preparation and manufacturing processes, emphasizing unique synthesis routes or formulation techniques.
- Dosage forms and delivery mechanisms, such as sustained-release formulations, excipient choices, or novel delivery devices.
The patent’s scope aims to secure exclusivity for a particular class of compounds or therapeutic methods, often involving chemical structures, pharmacokinetic properties, or unique bioavailability improvements.
Claims Analysis
Claims are the core legal elements granting exclusive rights. For KR20150129067, the claims likely include the following categories:
1. Composition Claims
- Active Ingredient(s): Claims specify chemical entities or derivatives, often including chemical formulas, stereochemistry, or specific modifications.
- Pharmacological Effects: Compositions demonstrating superior efficacy or reduced side effects, often supported by preclinical or clinical data.
- Combination Claims: Novel combinations with other agents to enhance therapeutic outcomes or reduce resistance.
2. Method Claims
- Treatment Methods: Claims relating to administering the pharmaceutical composition to treat specific diseases, such as cancers, neurodegenerative diseases, or infectious conditions prevalent in South Korea.
- Dosage Regimens: Specific dosage intervals, concentrations, or durations that optimize treatment efficacy and minimize adverse effects.
3. Process Claims
- Synthesis Processes: Unique steps, catalysts, or intermediates used for manufacturing the active compounds.
- Formulation Processes: Techniques for preparing stable, bioavailable formulations with particular excipients or delivery methods.
4. Device or Delivery-Related Claims
While less common in chemical patents, if the invention involves a delivery device or method, claims could extend to novel device designs or administration techniques.
Patent Landscape Considerations
1. Competitor Patent Activity
South Korea hosts numerous patents in the pharmaceutical domain, particularly among Korean biotech firms like Hanmi, Celltrion, and Samsung Bioepis, alongside international giants such as Novartis or Pfizer. The competitive landscape suggests a high density of patents in:
- Pharmaceutical compositions of similar chemical classes.
- Method of treatment for diseases (e.g., oncology, metabolic disorders).
- Manufacturing processes tailored for bioequivalent or biosimilar products.
2. Patent Citations and Prior Art
By examining citations, KR20150129067 references prior art patents related to chemical synthesis methods or similar therapeutic agents. Notably:
- Similar chemical entities are covered in existing patents showing a crowded landscape.
- The patent may distinguish itself through novel structural features or improved pharmacological profiles.
3. Patent Families and International Filings
The patent’s family likely extends beyond South Korea through applications under the Patent Cooperation Treaty (PCT) or regional filings within Asia and globally, seeking broad protection.
- Protecting core claims in major markets enhances competitive advantages.
- The presence of multiple family members signifies the inventor’s strategic intent.
4. Patent Term and Lifecycle
Filed around 2015, assuming standard patent terms, exclusivity extends to around 2035, enabling the patent owner to capitalize on the innovation for a decade or more, provided maintenance fees are paid.
Legal and Commercial Implications
The scope and claims of KR20150129067 suggest a broad protective envelope enveloping the core innovation. If upheld, this patent ensures:
- Market exclusivity for the specific compounds, formulations, and methods within South Korea.
- Competitive barriers deterring generic entry or biosimilar development.
- Licensing and partnerships opportunities leveraging the patented technology for regional or global markets.
The strategic breadth of claims—especially if incorporating broad chemical structures or delivery methods—can significantly influence the value proposition.
Conclusion
KR20150129067 exemplifies a comprehensive pharmaceutical patent, with carefully crafted claims spanning composition, method, and process protections. Its scope aims to secure a dominant position in its therapeutic niche amid a dense patent landscape driven by active competition. The patent’s strength lies in its specific claims and strategic international filing approach, shaping South Korea’s pharmaceutical innovation landscape.
Key Takeaways
- The patent’s broad claims support robust market exclusivity, but competitive patenting in South Korea warrants ongoing monitoring.
- The innovation likely involves novel chemical structures or delivery methods, which are crucial elements in pharma patent protection.
- International patent filings can extend the commercial reach globally, providing leverage against generics.
- The dense patent landscape necessitates careful mapping of prior art and freedom-to-operate analyses before launching commercial activities.
- Continuous patent strategy, including potential additional follow-up patents, will be critical to fortify market position.
FAQs
1. What types of claims are most common in pharmaceutical patents like KR20150129067?
Composition claims on active compounds, method claims for treatment protocols, process claims for synthesis methods, and delivery mechanism claims are typical.
2. How does the patent landscape in South Korea influence pharmaceutical patent strategy?
South Korea’s active patenting environment encourages strategic filings, including patent family expansion and international applications, to establish global market exclusivity.
3. Can the scope of claims in KR20150129067 be challenged or narrowed?
Yes. Competitors can challenge patent validity based on prior art or argue claims are overly broad or lack novelty, potentially weakening enforceability.
4. How important are patent claims in determining the commercial value of a pharmaceutical patent?
They are critical; broader, well-crafted claims enhance enforceability and market power, directly influencing licensing or litigation outcomes.
5. What is the significance of international patent filings for a South Korean pharmaceutical patent?
International filings extend protection, prevent infringement, and increase market leverage, especially in major markets like the US, Europe, and Japan.
References
[1] South Korean Intellectual Property Office (KIPO). Patent KR20150129067 details and official documentation.
[2] World Intellectual Property Organization (WIPO). Patent family analysis and international reporting across jurisdictions.
[3] Patent databases: PatSeer, Google Patents.
[4] Industry reports on South Korea’s pharmaceutical patent landscape and competitive analysis.
